Heterologous Production of the D-Cycloserine Intermediate O-Acetyl-L-Serine in a Human Type II Pulmonary Cell Model

Scientists determined D-cycloserine to be the optimal candidate for anti-tuberculosis cell therapy due to its effectiveness, relatively short biosynthetic pathway, and its low-resistance incidence.